Pharma-Bio Serv (OTCMKTS:PBSV) Stock Price Passes Below 200-Day Moving Average – Time to Sell?

Pharma-Bio Serv, Inc. (OTCMKTS:PBSV) passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.63 and traded as low as $0.54. Pharma-Bio Serv shares last traded at $0.54, with a volume of 5,550 shares traded.

Pharma-Bio Serv Trading Down 8.1 %

The business has a 50 day simple moving average of $0.61 and a 200-day simple moving average of $0.63. The stock has a market capitalization of $12.44 million, a price-to-earnings ratio of -18.07 and a beta of 0.59.

Pharma-Bio Serv (OTCMKTS:PBSV) last released its earnings results on Monday, September 16th. The company reported ($0.01) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.03 by ($0.04). The company had revenue of $2.42 million during the quarter, compared to analysts’ expectations of $3.50 million. Pharma-Bio Serv had a negative net margin of 7.81% and a negative return on equity of 5.81%.

Pharma-Bio Serv Company Profile

Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies.